Regional Gastrointestinal Absorption of Apixaban in Healthy Subjects
Author:
Affiliation:
1. Pfizer Inc.; Groton CT USA
2. Bristol-Myers Squibb; Princeton NJ USA
3. PRA Health Services; Raleigh NC USA
4. GlaxoSmithKline; King of Prussia PA USA
Funder
Bristol-Myers Squibb
Pfizer
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Reference15 articles.
1. Bristol-Myers Squibb Company PI Eliquis (apixaban) prescribing information 2017 http://packageinserts.bms.com/pi/pi_eliquis.pdf
2. Apixaban, an oral, direct factor Xa inhibitor: single-dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects;Frost;Br J Clin Pharmacol,2013
3. Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects;Frost;Br J Clin Pharmacol,2013
4. Effects of age and sex on the single-dose pharmacokinetics and pharmacodynamics of apixaban;Frost;Clin Pharmacokinet,2015
5. Evaluation of crushed tablet for oral administration and the effect of food on apixaban pharmacokinetics in healthy adults;Song;Clin Ther,2016
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treating cancer-associated venous thromboembolism: A practical approach;European Journal of Cancer;2024-09
2. Clinical Implications of Co‐administering Apixaban with Key Interacting Medications;Clinical Pharmacology in Drug Development;2024-07-24
3. Apixaban Pharmacokinetics and Bioequivalence of Two Tablet Formulations: A Randomized, Open‐Label, Crossover Study, Fasting Condition in Healthy Indonesian Volunteers;Clinical Pharmacology in Drug Development;2024-04-30
4. Venous thrombosis during systemic antitumor therapy: risks, prognosis, treatment. A review;Journal of Modern Oncology;2024-03-05
5. Anticoagulation and antiplatelet therapy in short bowel syndrome: A systematic review;Intestinal Failure;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3